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1. Introduction  
Periodontal disease is one of the major dental pathologies that affect human populations 
worldwide at high prevalence rates (Petersen, 2003). Periodontal diseases represents a 
family of heterogeneous chronic inflammatory lesions that involve the periodontium, a 
connective tissue protected by the epithelium, important to attach the teeth to the bone in 
the jaws and to support the teeth during function (Taylor, 2003). It is well known that 
periodontal diseases are caused by the interaction between periodontopathogens, almost 
gram-negative bacteria that grows on the teeth, and the host immune response to the 
chronic infection which results in tissue destruction (Ratcliff & Johnson, 1999; Reynolds & 
Meikle, 1997).  
Gingivitis and periodontitis are the two main periodontal diseases and may be present 
concurrently. Gingivitis is a form of periodontal disease in which gingival tissues are 
inflamed but their destruction is mild and reversible while periodontitis is a chronic 
inflammatory response to the subgingival bacteria with irreversible changes (Armitage, 
1999). Periodontium destruction is characterized by loss of connective tissue attachment and 
bone around the teeth in conjunction with the formation of periodontal pockets due to 
apical migration of the junctional epithelium (Champagne et al., 2003). Periodontal disease 
progression is episodic in nature on a tooth site level, but more recently, it has been realized 
that it is principally patient-based rather than site-based (Zia et al., 2011); the host related 
risk factors could be the key to better understand disease evolution. The available evidence 
shows that important risk factors for periodontal disease relate to poor oral hygiene, tobacco 
use, excessive alcohol consumption, stress, and diabetes mellitus (Laurina et al., 2009; Taylor 
& Borgnakke, 2008). Degrees of inflammation and fibrosis depend on these risk factors but 
recently the genetic basis of many aspects of the periodontal host response has been 
discussed in reference to disorders predisposing to periodontal disease (Bartold & 
Narayanan, 2006; Kinane & Hart, 2003). 
Clinical hallmarks of periodontal disease are represented by the redness and swelling of the 
gingival margin around the neck of the teeth, recession of the gums, tooth looseness, 
changes in tooth alignment and halitosis (Taylor, 2003). Recently, it has been accepted that 
during chronic periodontal disease, morphological changes in the architecture of the 
extracellular matrix of the gingiva could occur and lead to gingival enlargement. This refers 
to the overgrowth of the gingiva characterized by the expansion and accumulation of the 
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connective tissue with occasional presence of increased cell number. These changes are 
unspecific, appearing in gingival enlargement associated to chronic inflammation but also 
when other risk factors exist (inheritance, systemic diseases, such as diabetes mellitus, and 
drugs administration). The most common form of gingival overgrowth is that drug-induced, 
by anti-seizure drugs, such as phenytoin, immunosuppressive agents, such as cyclosporine, 
and some calcium antagonists (verapamil, diltiazem, dihidropyridines, most notably 
nifedipine) (Dongari-Bagtzoglou et al., 2004; Seymour, 2006).  
Histological assessment showed that independently of the etiological factor involved, 
changes of the mucosa refer both to the gingival epithelium and the lamina propria (Banita 
et al., 2008, 2011). There is now general agreement that all gingival overgrowth lesions 
contain fibrotic or expanded connective tissue with various levels of inflammation and an 
enlarged gingival epithelium. As soon as plaque accumulates adjacent to the gingival 
margin, inflammatory cells infiltrate in the subjacent connective tissue and initiate its 
destruction. Simultaneously with collagen destruction, wound repair occurs, which results 
in fibrosis and scarring coexisting at the foci of inflammation (Bartold & Narayanan, 2006). 
According to this sequence of events, the stages of inflammation, matrix destruction and 
repair succeed each other in the development of periodontal disease.  
Important player for the regulation of gingival connective tissue homeostasis is the 
fibroblast, cell able to synthesize and breakdown the collagen fibers and other proteins from 
the ground substance. In vitro studies have shown that fibroblasts from human normal 
gingiva produce collagens type I and type III, while cells derived from gingiva of patients 
with chronic periodontitis failed to produce detectable amounts of type III collagen 
(Hammouda et al., 1980; Chavier et al., 1984, as cited in Bartold & Narayanan, 2006). 
Buduneli et al. (2001a) investigated total collagen content and collagen type I, III, IV, V and 
VI content in gingival connective tissue of chronic periodontitis as well as aggressive 
periodontitis patients and clinically healthy subjects. It was suggested that different collagen 
types present in various periodontitis categories may be related with diverse pathogenic 
mechanisms acting in these diseases. In our previous studies we observed the abundance of 
type I collagen in the extracellular matrix of the gingival tissue obtained from patients with 
chronic periodontitis. In accordance with reference data, we suggest two explanations for 
this: despite the degradation of the fibrilar collagen, cells are able to synthesize a new type 
of collagen, type I trimer which accumulates in the gingiva (Narayanan et al., 1985, as cited 
in Bartold & Narayanan, 2006) or that inflamed human gingiva contains fibroblasts with 
different phenotype than those from the normal tissue, the myofibroblasts, able to 
synthesize a large amount of collagen.  
Pathogenic pathways involved in the imbalance of connective tissue homeostasis in 
periodontal inflammatory diseases are complex, and specific mediation is not completely 
understood. Activation of matrix metalloproteinases (MMPs) is one of the most important 
evolving under a rigorous control.  
Growth factors and cytokines play an important role in regulation of the gingival 
extracellular matrix turnover. Tumor necrosis factor-ǂ (TNF-ǂ) and interleukins induce the 
expression of MMPs while transforming growth factor-ǃ (TGF-ǃ) down-regulates their 
synthesis and secretion and promotes the production of their natural tissue inhibitors, 
TIMPs (Bartold & Narayanan, 2006). Connective tissue growth factor (CTGF) is another 
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important mediator of tissue remodelling which stimulates fibroblasts to produce 
extracellular matrix constituents, so its expression correlates positively with the degree of 
gingival fibrosis (Heng et al., 2006; Trackman & Kantarci, 2004). Local conditions favour 
angiogenesis in periodontal tissues being characterized by an increased expression of the 
vascular endothelial growth factor (VEGF), this cytokine acting also to complete the greater 
ability of regeneration of the gingiva (Lucarini et al. 2009).   
At the beginning, specialists tried to diagnose the stage of periodontal disease depending 
on the relation between the clinical appearances and the presence of some specific cell 
populations or specific matrix components (Havemose-Poulsen & Holmstrup, 1997; 
Romanos et al., 1993). Traditional clinical measurements (probing pocket depth, bleeding 
on probing, clinical attachment loss, plaque index) used for the diagnosis of periodontium 
health are often of limited usefulness because they are not sufficiently accurate to discern 
between previous periodontal disease and present disease activity. There is a need for 
development of new diagnostic tools to allow earlier detection of active disease, predict 
disease progression and evaluate the response to periodontal therapy, thereby improving 
the clinical management of patients with periodontal diseases. Advances in periodontal 
diseases diagnostic research are moving toward methods whereby periodontal risk can be 
identified and quantified by objective measures such as biomarkers. Gingival crevicular 
fluid (GCF) and salivary levels of several growth factors, cytokines and enzymes of host 
origin appear to hold the greatest promise as valuable biomarkers in assessing 
development of periodontal disease (Buduneli & Kinane, 2011; Giannobile et al., 2003; 
Gurkan et al., 2008; Goncalves et al., 2009; Kaufman & Lamster, 2000; Pisoschi et al., 2010; 
Wright et al., 2000). 
In the last decade, scientists began to use signaling molecules such as growth factors in their 
quest to restore destroyed tooth support (Anusaksathien & Giannobile, 2002) and this 
reason request a very good knowledge of the biological actions of growth factors, both 
summative and redundant, in the specific “milieu” of periodontal diseases.  
This paper highlights a brief review of the literature on growth factors involvement in 
periodontal disease and our contribution in this field, in order to sustain their use as 
biomarkers of active periodontal disease and future therapeutic tools.  
2. Changes of the gingival tissues in periodontal disease 
Periodontium includes four tissues located near the teeth: i) root cementum, ii) periodontal 
ligament; iii) alveolar bone, and iv)the part of the gingiva facing the tooth (dentogingival 
junction) (Nanci & Bosshardt, 2006). Gingiva or gums represent the mucosal tissue that 
covers the alveolar bone. Healthy gingiva is pale pink or pigmented and wrap tightly 
around the neck of the teeth (Taylor, 2003). Histologically, gingiva consists of two types of 
tissues - the epithelium that covers a connective tissue, chorion or lamina propria. A 
keratinized stratified squamous epithelium protects the lamina propria of the gingiva on its 
masticatory surfaces and a non-keratinized epithelium protects the lamina propria on its 
crevicular and junctional surfaces. During normal or pathological conditions such as 
inflammation, the periodontal connective tissues, including the gingiva, undergo many 
changes. Clinically detected gingival overgrowth – term used to substitute the former 
”gingival hypertrophy” or ”gingival hyperplasia”, because the changes of this clinical 
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condition are more complex (Dongari-Bagtzoglou et al., 2004) - is one of the alterations 
recently postulated to occur in chronic periodontitis. It is caused by a variety of etiological 
factors and is exacerbated by local bacterial biofilm accumulation, because the 
periodontopathogens products act on the gingival tissues activating cellular events that 
induce the alteration of connective tissue homeostasis and the destruction of the alveolar 
bone (Reynolds & Meikle, 1997). Clinical characteristics of different forms of gingival 
overgrowth have been previously reviewed (Marshall & Bartold, 1998, 1999; Seymour et al., 
2000). Gingival overgrowth is characterized by enlarged and occasionally inflamed gums 
(the interdental papilla and the free gingival margins increase in size and thickness 
progressively covering the tooth crown). Besides the one associated with periodontal 
disease, gingival overgrowth can be inherited (hereditary gingival fibromatosis), sometimes 
associated with other systemic diseases (such as diabetes mellitus) or with idiopathic origin. 
The majority of cases, however, occur as a side-effect of systemic medications, including the 
anti-seizure drug phenytoin, the immunosuppressive agent cyclosporin A and certain anti-
hypertensive calcium-channel-blockers (verapamil, diltiazem and dihidropyridines, most 
notably nifedipine) (Seymour, 2006; Trackman & Kantarci, 2004). There is now general 
agreement that all gingival overgrowth lesions contain fibrotic or expanded connective 
tissues with various levels of inflammation and an enlarged gingival epithelium. The 
degrees of inflammation, fibrosis, and cellular pattern depend on the risk factor if it is 
identified: the duration, dose, and identity of the drug, the quality of oral hygiene, and the 
individual susceptibility that stems from genetic factors and environmental influences. 
Histological assessment showed that independently of the etiological factor involved, 
changes of the mucosa are unspecific and refer both to the gingival epithelium and the 
lamina propria. Our previous studies of chronic periodontitis gingival samples revealed 
epithelial hypertrophy with a thick stratified squamous epithelium showing an alternation 
between keratinized and non-keratinized areas with the increase of the spinous layer 
(acanthosis) associated with acantholysis (Banita et al., 2008, 2011). Epithelium bended 
deeply into the lamina propria to form the so called “rete pegs” (Fig.1.).  
 
 
Fig. 1. Gingival enlarged epithelium in chronic periodontitis (Masson staining x 10) 
Gingival tissues assessed showed also the thickness of the lamina propria due to an 
excessive deposition of connective tissue. It was an important accumulation of thick collagen 
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bundles with a various number of fibroblasts and the constant presence of pro-inflammatory 
cells (lymphocytes and macrophages) and numerous de novo capillaries (Fig.2). 
 
Fig. 2. Infiltration of connective tissue with inflammatory cells in periodontitis, de novo 
capillaries (Haematoxylin & Eosin staining x 10) 
Using silver impregnation we noticed that the ratio between collagen types was changed, 
the extent of the yellowish coloured areas proving the presence of more type I collagen 
(Fig.3).  
 
Fig. 3. Abundant collagen type I in chronic periodontitis (Gömöri silver impregnation x 4,5) 
Our observations are in agreement with those of Lorencini and coworkers (2009) who, in 
their experimental model of ligature-induced periodontal disease noticed also this 
paradigm. They hypothesized that a kind of “frustrated repair” of the extracellular matrix 
can occur simultaneously with collagen breakdown and that the new configuration of the 
fibers can contribute to periodontal disease progression (Lorencini et al., 2009). Other 
authors postulated that with the developing of inflammatory lesion, the gingival collagens 
become more soluble, with increasing amount of collagen type V and the appearance of a 
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new collagen, type I trimer (Narayanan et al., 1985, as cited by Bartold & Narayanan, 2006). 
Taken together these results prove without doubt that there is a permanent link between 
inflammatory cell populations and extracellular matrix turnover in inflammatory gingival 
overgrowth. Gingival tissues are recognized for their remarkable ability of regeneration and 
healing after wounding. The ability of regeneration of the gingival epithelium is compulsory 
in order to maintain the homeostasis of the gingival mucosa. Lamina propria has also the 
ability to heal very quickly after wounding. Some areas of interest for researchers are the 
biological processes that control how the periodontal tissues respond to wounding, and how 
cells from the different tissues of the periodontium interact when more than one periodontal 
tissue is affected. It is generally agreed that gingival overgrowth results from an increase of 
extracellular matrix macromolecules infiltrated with various numbers of inflammatory cells.  
3. Extracellular matrix homeostasis in periodontal disease 
Connective tissue remodelling is essential for normal growth and development and many 
diseases have long been associated with the imbalance of the breakdown of the collagenous 
matrix of different tissues. Complex pathogenic pathways control the balance 
synthesis/degradation of the extracellular matrix. Macromolecules of interstitial connective 
tissues and basement membranes may be degraded by: i) matrix metalloproteinase (MMP)-
dependent, ii) plasmin-dependent, iii) polymorphonuclear leukocyte serine proteinase-
dependent reactions, and iv) a phagocytic pathway based on intracellular digestion of 
internalized material by lysosomal cathepsins (Birkedal-Hansen et al., 1993). 
Since the early 1990s, interest has focused on works showing that connective tissue cells 
synthesize and secrete a family of proteinases, the MMPs, which can digest extracellular 
matrix macromolecules and play a major role in connective tissue breakdown.  
3.1 Matrix metalloproteinases 
Matrix metalloproteinases (MMPs), or matrixins, are enzymes derived from many types of 
mesenchymal cells, monocytes, macrophages and keratinocytes and can synergistically 
digest most of extracellular matrix (ECM) macromolecules (Reynolds et al., 1994; Whittaker 
& Ayscough, 2001). The MMP gene family encodes more than 20 human metal-dependent 
endopeptidases (Stamenkovic, 2003) divided into major five groups (see Tabel 1).  
As we already mentioned, gingival tissue remodelling involve the balance between 
synthesis and accumulation of matrix components and their breakdown under the catalitic 
action of metalloproteases. Several MMPs have been identified in the inflamed gingival 
tissues: MMP-1, -2, -3, -8, -9, -13, produced by the keratinocytes, macrophages, 
polymorphonuclear leukocytes (Banita et al., 2011; Bartold & Narayanan, 2006; Bildt et al., 
2008; Kubota et al., 2008; Kumar et al., 2006). Their activity could be different depending on 
the severity of disease and the needs for extracellular matrix digestion.  
In a previous study regarding the expression of MMPs in gingival samples of chronic 
periodontitis we observed an enhanced expression of MMP-1 in keratinocytes from diseased 
epithelial layers (Fig.4). In some cases, MMP-1 expression extended to the lamina propria as 
inflammation progressed. MMP-1 increased activity could explain the change of collagen 
quality and quantity, since its preferred substrates are the type I and type III collagens.  
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Type of MMPs Substrates Members 
Collagenases 
Native fibrilar collagens  
(I, II, III, VII, VIII, X) 
Gelatins (limited) 
Other ECM molecules 
MMP-1 (Collagenase 1) 
MMP-8 (Neutrophil collagenase) 
MMP-13 (Collagenase 3) 
Gelatinases 
Denaturated collagens (gelatins) 
Type IV collagen  
Other ECM molecules 
MMP-2 (Gelatinase A) 
MMP-9 (Gelatinase B) 
Stromelysins 
Collagens III-V  
Gelatins (limited) 
Other ECM molecules  
MMPs 
MMP-3 (Stromelysin 1) 
MMP-10 (Stromelysin 2) 
Matrilysins 
Collagen IV and X, gelatins 
Other ECM molecules  
MMPs  
MMP-7 (Matrilysin 1) 
MMP-26 (Matrylisin 2) 
Membrane type - 
MMPs  
Collagen (I, II, III) 
Pro-MMP-2 
Other ECM molecules  
MT1-MMP - MT6-MMP 
(MMP-14, MMP-15, MMP-16, 
MMP-17, MMP-24, MMP-25) 
Table 1. Major types of matrix metalloproteinases (MMPs)  
Several other researchers reported an intense MMP-1 collagenolytic activity in fibroblasts 
and macrophages resident in the periodontal tissue (Beklen et. al., 2007; Kubota et al., 2008) 
and focused on the interrelation between MMP-1 and MMP-3 in order to amplify the 
proteolysis in chronic periodontitis (Beklen et. al., 2007). 
 
 
Fig. 4. Expression of MMP-1 in gingival epithelium in chronic periodontitis (IHCx40) 
Regarding MMP-2, we observed an increased expression of this enzyme in many 
keratinocytes from the basal layer and in some cells from the basement membrane (Fig. 5); 
the active form of MMP-2 increased significantly as inflammation progressed.  
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Fig. 5. Increased expression of MMP-2 in gingival epithelium and basement membrane in 
chronic periodontitis (IHCx20) 
Its expression and distribution is justified by the fact that this gelatinase has an important 
role in the degradation of denatured collagen (predigested with MMP-1) and type IV 
collagen of the basement membrane, and these processes are increased in various stages of 
periodontal disease progression. MMP-2 is also able to increase matrix degradation by 
MMP-13 and neutrophil collagenase (De Souza & Line, 2002). The degenerative process 
causes the loss of attachment apparatus between tooth, epithelium, and connective tissue 
which accelerates inflammation and deepening of periodontal pocket. In the last decade, 
many research groups reported the putative role of other MMPs (MMP-7, MMP-25, MMP-
26, MT1-MMP) as mediators of the alternating sequence inflammation-fibrosis during 
progression of periodontal disease (Emingil et al., 2006a, 2006b; Oyarzun et al., 2010).  
3.2 Tissue inhibitors of matrix metalloproteinases  
MMPs activity is controlled in vivo in three ways: i) these enzymes are synthesized and 
secreted as latent, inactive precursors and conversion to the active form require activation; 
ii) production of MMPs can be regulated by growth factors and cytokines; iii) their activity 
can be inhibited by endogenous serum and tissue inhibitors (Nagase, 1997, as cited by 
Bartold & Narayanan, 2006). Various tissues express one or more of the members of the 
most important group of inhibitors known as tissue inhibitors of MMP (TIMPs). These are 
specific inhibitors that bind MMPs in a 1:1 stoichiometry. All the four currently known 
TIMPs (TIMP-1, TIMP-2, TIMP-3, and TIMP-4) are very well conserved since they have been 
identified in vertebrates, including humans, insects and even in the nematode, Caenoharbditis 
elegans (Brew et al., 2000). Their expression is rigorous regulated during development and 
tissue remodelling under pathological conditions associated with unbalanced MMP 
activities, and changes of TIMP levels are considered to be important because they directly 
affect the level of MMP activity (Visse & Nagase, 2003). TIMP-1 and TIMP-3 expression is 
inducible, whereas TIMP-2 is largely constitutive (Verstappen & Van den Hoff, 2006). TIMPs 
are produced in many tissues, although not every tissue expresses all four inhibitors. Most 
mesenchymal and epidermal cells are able to produce TIMPs in various conditions (Rowe et 
al., 1997, as cited by Verstappen & Van den Hoff, 2006), but TIMP-4 expression is restricted 
to neural tissue, gonads, breast and skeletal muscle (Lambert et al., 2004).  
www.intechopen.com
 Growth Factors and Connective Tissue Homeostasis in Periodontal Disease 
 
63 
Our studies regarding the modulation of MMP/TIMP balance in gingival overgrowth 
associated with periodontitis lead to the following observations related to TIMP activity. We 
noticed that the immune reaction for TIMP-1 was positive in few epithelial cells in 
periodontitis-affected gingival samples assessed (Banita et al., 2011). For TIMP-2 the 
immune response was quite different. We observed extended areas of TIMP-2 intense 
positive cells in the epithelium (Fig.6) and a lot of TIMP-2 positive pro-inflammatory cells 
and few fibroblasts in the lamina propria (Fig.7). 
 
Fig. 6. TIMP-2 expression in gingival epithelium in periodontitis–affected gingiva (IHCx40) 
 
Fig. 7. TIMP-2 expression in periodontitis-affected gingival lamina propria (IHCx20) 
Our results showed increased levels for both MMPs and TIMPs assessed in periodontitis-
affected gingival tissue and are in accordance with other similar studies. Up-regulated MMPs 
and TIMPs expression with a modified MMPs/TIMPs ratio depending on the type of lesion 
(destruction or fibrosis) indicate that the imbalance between degradation and synthesis of the 
extracellular matrix components persists in periodontitis-affected gingiva and is responsible 
for an increased tissue breakdown in periodontitis. The reciprocal regulation of TIMPs and 
MMPs expression may depend on endogenous growth factors and cytokines.  
www.intechopen.com
 Pathogenesis and Treatment of Periodontitis 
 
64
4. Growth factors and cytokines in periodontal disease  
The balance between MMPs and TIMPs influence on extracellular matrix homeostasis in 
different types of tissues is tightly controlled by growth factors, a class of polypeptide 
hormones. Other polypeptide mediators that affect matrix synthesis include several 
cytokines - interleukins (IL-1, IL-4, IL-6, IL-10) and tumour necrosis factor-ǂ (TNF-ǂ). By 
binding to specific cell-surface tyrosine kinase receptors, growth factors are able to regulate 
significant cellular events in tissue regeneration and repair, including cell growth, 
proliferation and differentiation, chemotaxis, angiogenesis, and extracellular matrix 
synthesis (Giannobile, 1996). Growth factors are classified as biological mediators that lack 
specificity sequestered in the extracellular matrix and molecules available from the 
circulation (Bartold & Narayanan, 2006). Growth factors demonstrate pleiotropic or multiple 
effects on wound repair in almost all tissues, including the periodontium.  
Some of the most important growth factors exerting functions in healthy and diseased 
periodontium are listed below: 
a. Platelet-Derived Growth Factor (PDGF)  
b. Fibroblast Growth Factors (a-FGF and b-FGF) 
c. Transforming Growth Factors (TGF-ǂ and -ǃ) 
d. Connective Tissue Growth Factor (CTGF) 
e. Vascular Endothelial Growth Factor (VEGF)  
f. Insulin-like Growth Factors (IGF-I, IGF-II)  
g. Epidermal Growth Factor (EGF)  
h. Hepatocyte Growth Factor (HGF) 
After an injury occurs, healing proceeds in a succession of “well orchestrated” cell-cell and 
cell-extracellular matrix interactions. In the process of normal wound healing, the growth 
factors act in conjunction to form a complex arrangement of molecules that regulate cellular 
activity and bordering the wound (Giannobile, 1996). Table 2 lists the sources and the main 
effects of some growth factors and cytokines important for extracellular matrix remodelling.  
The role of growth factors is now recognized in connective tissue homeostasis during 
inflammation and fibrosis. Tissue repair studies conducted on animals provide evidence 
that soft tissue wound healing is enhanced by EGF, TGF-ǂ and ǃ, PDGF, acidic and basic 
FGF. Combinations of different growth factors yield greater repair than can be achieved by 
individual factors alone (Giannobile, 1996). 
Growth factors mediate many events associated with turnover, repair and regeneration of 
periodontal tissues. Gingival epithelial cells, gingival fibroblasts, and periodontal ligament 
fibroblasts are the major cells involved in tissue repair. An appropriate response of these 
target cells to various growth factors depends on the expression of corresponding receptors.  
a) Platelet-Derived Growth Factor. In vitro and in vivo studies suggest PDGF as the most 
thoroughly described growth factor associated with periodontal health. There are different 
isoforms of PDGF (PDGF-AA, -AB, -BB), and all have been shown to have a fibroblast 
proliferative activity in vitro (Giannobile, 1996). PDGF is present in increased levels in the 
human inflamed gingiva and is mainly localized to the pocket epithelium (Pinheiro et al., 
2003).  
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Growth Factor Source Effect
PDGF isoforms  
Platelets 
Macrophages 
Keratinocytes 
Fibroblast and macrophage 
chemotaxis 
Fibroblast proliferation 
Extracellular matrix synthesis 
FGF  
Macrophages 
Endothelial cells  
Fibroblast proliferation 
Angiogenesis 
TGF-ǃ1, 2 Platelets 
Macrophages  
Fibroblast and macrophage 
chemotaxis 
Extracellular matrix synthesis 
Secretion of protease inhibitors 
CTGF 
Epithelial cells 
Vascular cells 
Extracellular matrix synthesis 
EGF  
TGF-ǂ 
Platelets  
Macrophages 
Keratinocytes 
Reepithelization 
IGF 
Plasma 
Platelets  
Endothelial and fibroblast 
proliferation 
Collagen synthesis 
VEGF 
Keratinocytes 
Macrophages  
Angiogenesis 
IL-1  Neutrophils  
Activate growth factor expression 
in macrophages, keratinocytes and 
fibroblasts 
TNF-ǂ  Neutrophils  
Activate growth factor expression 
in macrophages, keratinocytes and 
fibroblasts 
Table 2. Sources and major functions of several growth factors and cytokines  
It is possible that expression of PDGF contributes to the inflammatory changes that occur 
during periodontal diseases. PDGF supports the healing in the periodontal soft tissues in a 
variety of ways. Since PDGF is chemotactic for fibroblasts, it induces collagen synthesis, but 
also stimulates fibroblasts to synthesize the proteoglycans that supply the framework for 
extracellular matrix development. Lipopolysaccharide, the major constituent of the cell 
walls of gram-negative bacteria, inhibits the proliferation of gingival fibroblasts and PDGF 
decreases this inhibitory effect (Bartold & Narayanan, 1992). Reported data suggest that 
there may be cell specific differences in response to PDGF isoforms critical to periodontal 
healing that may be exploited in the development of efficient therapies (Mumford et al., 
2001).  
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b) Transforming Growth Factor-β (TGF-β). TGF-ǃ superfamily consists of several multifunctional 
structurally related growth and differentiation factors associated to the inflammatory 
response, known also to be involved in apoptosis, angiogenesis, wound healing and fibrosis 
(Frank et al., 1996; Lawrence, 1995). There are three TGF-ǃ isoforms important for humans, 
TGF-ǃ1, 2 and 3; their amino acid sequences are 70-80% homologous but they can be 
distinguished by the effects on cell growth, biological interactions and receptor binding 
abilities (Frank et al., 1996). TGF-ǃ1 is expressed in epithelial, hematopoietic, and connective 
tissue cells (Massague, 1998). Because TGF-ǃ1 exhibits both pro-inflammatory and anti-
inflammatory properties besides its ability to stimulate synthesis of ECM molecules and to 
inhibit the breakdown of ECM, it has been intensively evaluated in relation to all types of 
gingival overgrowth.  
Regarding TGF-ǃ1 expression in chronic periodontitis, we noticed a positive reaction in 
some keratinocytes from the gingival basal epithelial layer (Fig.8), and pro-inflammatory 
cells infiltrating lamina propria (Fig.9).  
 
Fig. 8. TGF-ǃ1 expression in gingival epithelium in periodontitis (IHCx20) 
 
Fig. 9. TGF-ǃ1 expression in inflammatory cells infiltrating lamina propria of periodontitis-
affected gingiva (IHCx20) 
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Our results confirm that increased gingival inflammation is associated with high levels of 
TGF-ǃ isoforms. It is well known that TGF-ǃ is one of several cytokines able to regulate 
inflammation and immune responses and the fact that TGF-ǃ mediates leukocyte 
recruitment, adhesion and activation suggests that it play a key role in the host response to 
bacterial and immunological insults (Prime et al., 2004), even there is not a clear evidence for 
its role in the pathogenesis of the periodontal disease. But TGF-ǃ has also a marked effect on 
ECM homeostasis, being an important mediator of fibroblast proliferation and ECM 
synthesis. The inverse relationship between TGF-ǃ1 and MMP-1 expression in the gingival 
epithelium noticed in our studies could be in accordance with TGF- ǃ1 action as inhibitor of 
MMP-1 activity and proves that TGF-ǃ mediates a tight control of the MMP/TIMPs 
equilibrium and synthesis of matrix macromolecules. TGF-ǃ1 pro-fibrotic role could be 
explained also by the stimulation of collagen synthesis in lamina propria. There are 
considerable data supporting the fact that under pathological conditions, TGF-ǃ1 
orchestrates a cross talk between parenchymal, inflammatory and collagen expressing cells 
and have a key role in control inflammation and fibrosis (Buduneli et al., 2001b; Ellis et al., 
2004; Wright et al., 2001). The role of TGF-ǃ1 in gingival overgrowth must be considered in 
line with natural development of the periodontal lesion, as inflammation preceedes fibrosis, 
and with its stadial activity. First, it acts as a pro-inflammatory cytokine that mediate the 
recrutation of monocytes-macrophages, their adhesion and action at site lesion, suggesting a 
key role in the host-response to the presence of the bacterial products. Finally, as the 
inflammation progresses, TGF-ǃ1 overexpression in epithelial and fibroblasts could be a 
response to paracrine stimulation by other cytokines secreted by the pro-inflammatory cells. 
Despite the great interest for this growth factor, the precise role of TGF-ǃ1 in the 
pathogenesis of periodontitis-induced gingival overgrowth is still under debate. 
c) Connective Tissue Growth Factor (CTGF). The CCN family consists of six multifunctional 
members including CCN1 (Cyr61), CCN2 (connective tissue growth factor, CTGF), CCN3 
(Nov), CCN4 (WISP1), CCN5 (WISP2), and CCN6 (WISP3) (Brigstock, 2003). The functions 
of this family include embryogenesis, wound healing, and regulation of ECM production. 
CTGF is a matricellular cysteine-rich peptide that plays a variety of important roles in cell 
development and differentiation and acts to promote fibrosis in many different tissues in 
cooperation with other growth factors and extracellular matrix proteins (Leask & Abraham, 
2003). These findings rise the hypothesis that CTGF could play a role in gingival fibrosis.  
In periodontitis, we observed a different pattern of CTGF distribution in gingival structures. 
Many samples showed an intense positive reaction in basal and parabasal epithelial layers 
but also in structures from the lamina propria (Fig.10). Higher CTGF staining in overgrown 
gingiva was accompanied by an increased number of fibroblasts and collagen fibers, in 
accordance with CTGF contribution to increase fibrosis. Fibrosis, as well as physiological 
wound repair and inflammation, involves the same molecules and cellular events (Bartold & 
Narayanan, 2006). As a consequence of inflammation, fibrosis can be the result of several 
events: abnormal release of mediators and persistence of changes in the abnormal growth 
factor/cytokine profile, and proliferation of cells with an abnormal phenotype responsible 
for the excessive extracellular matrix synthesis that characterize fibrosis. CTGF alone does 
not promote fibrosis. Recent studies indicate that CTGF binds to other factors, resulting in 
either inhibition or stimulation activity (Kantarci et al., 2006, Trackman & Kantarci, 2004). 
CTGF binding to VEGF results in inhibition of VEGF while CTGF binding to TGF-ǃ1 is 
reported to be stimulatory (Trackman & Kantarci, 2004). Therefore simultaneous production 
of both TGF-ǃ1 and CTGF is required to sustain fibrosis in gingival overgrowth.  
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Fig. 10. Intense expression of CTGF in periodontitis-affected gingival epithelium (IHCx20) 
d) Basic Fibroblast Growth Factor (bFGF or FGF-2). FGFs are a family of at least 23 structurally 
related polypeptides known to play a critical role in angiogenesis and mesenchymal cell 
mitogenesis. In periodontium, FGF-2 is present in the extracellular matrix, as well as in the 
cementum and can function as a local factor at the site (Gao et al., 1996). In periodontitis, the 
presence of bFGF was reported in the gingival epithelium, inflammatory cells and 
connective tissue (Laurina et al., 2009). They noted also a more increased expression of FGF 
receptor (FGFR) in hyperplasic gingival tissue compared to normal. One of their conclusions 
was that the expression of growth factors and their receptors in sulcular epithelium was 
lower than into the gingival epithelium and seems to be specific for periodontitis (Laurina et 
al., 2009). 
e) Epidermal Growth Factor (EGF). EGF is a multifunctional cytokine with a variety of 
biological functions including epithelial growth and differentiation, and wound healing. In 
the periodontium, EGF seems to exert only a minor effect on the promotion of mitogenesis, 
chemotaxis, or matrix synthesis in periodontal ligament fibroblasts (Giannobile, 1996). He 
supposed that EGF receptors (EGF-R) localization in periodontal ligament fibroblasts may 
stabilize the periodontal ligament fibroblast phenotype or cellular physical characteristics. 
Buduneli et al. (2001c) evaluated the expression of EGF-receptor (EGFR) in frozen sections of 
cyclosporine (CsA)-induced gingival overgrowth using immunohistochemical and 
semiquantitative techniques. Gingival biopsies were obtained from 12 renal transplant 
patients receiving CsA as well as from 9 systemically and periodontally healthy individuals. 
The authors suggested that CsA affects EGFR metabolism in gingival keratinocytes resulting 
in an increased number of cell surface receptors, which may eventually play a role in the 
pathogenesis of gingival tissue alterations. In chronic periodontitis, EGFR was regionally 
detected in gingival epithelium in some cases (Laurina et al., 2009). Other in vivo studies are 
needed to reveal the precise effects of EGF on soft periodontal tissue healing.  
f) Insulin-Like Growth Factors (IGFs). IGFs are a family of mitogenic proteins that control 
growth, differentiation, and the maintenance of differentiated function in numerous tissues. 
The IGF family includes three ligands (insulin, IGF-I, and IGF-II), their corresponding cell 
surface receptors (IR, IGF-IR, and IGF-IIR), and at least six IGF-binding proteins (IGFBPs) 
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able to bind circulating IGFs and modulate their biological actions. Studies have suggested 
that IGF-I has an important involvement in periodontal wound healing and regeneration. 
IGF-I is chemotactic for cells that come from the periodontal ligament and demonstrates 
significant effects on the mitogenesis of periodontal ligament fibroblasts (Giannobile, 1996). 
IGF-I is able to prevent apoptosis in fibroblasts, to regulate DNA and protein synthesis in 
periodontal ligament fibroblasts in vitro and to enhance soft tissue wound healing in vivo 
(Werner & Katz, 2004). Regarding the IGF-IR expression in chronic periodontitis, Laurina et 
al. (2009) reported only a weak presence in the sulcular epithelium suggesting a potential 
role in regeneration of periodontal tissue. The effect of IGF-II on the metabolism of gingival 
fibroblasts is still uncertain. 
h) Hepatocyte growth factor (HGF). HGF is a multifunctional cytokine involved in the repair 
and regeneration of various tissues and their protection from injury (Matsumoto & 
Nakamura, 1997) and recently, it has been linked also to the development of periodontal 
disease (Ohshima et al., 2001; Ohnishi & Daikuhara, 2003). HGF may be closely involved in 
the pathogenesis and progression of periodontal disease because it stimulates excessive 
proliferation and invasion of gingival epithelial cells and impair the regeneration of deep 
collagenous structures in the periodontium (Ohshima et al., 2001). 
g) Vascular Endothelial Growth Factor (VEGF). Over the last two decades researchers have 
demonstrated that VEGF is a key regulator of physiological and pathological angiogenesis, 
because it induces endothelial cell proliferation, stimulates angiogenesis and increases 
vascular permeability (Ferrara, 2009). In the last decade, many groups focused their research 
on the angiogenic factors that contribute to periodontal healing. In periodontitis patients, 
VEGF was detected within vascular endothelial cells, neutrophils, plasma cells, and 
junctional, pocket and gingival epithelium (Booth et al, 1998). In a previous study on 
biopsies obtained from patients with type 2 diabetes associated gingival overgrowth, we 
detected VEGF expression in keratinocytes from the basal and spinous layers and in many 
de novo capillaries (Pisoschi et al., 2009). Other authors reported increased VEGF expression 
in epithelial cells and endothelial cells in periodontitis-affected gingiva (Guneri et al., 2004; 
Keles et al., 2010; Lucarini et al., 2009). Giannobile et al. (2003) suggested that VEGF could be 
an important growth factor for the onset of gingivitis and its progression to periodontitis. 
Taken together these observations conclude that VEGF expression is related to both 
maintenance of periodontal health and periodontal tissue destruction but the precise 
mechanism of neovascularization remains in debate.  
5. Gingival crevicular fluid and salivary growth factors as potential 
biomarkers of periodontal disease 
Traditional periodontal diagnostic methods include assessment of clinical parameters 
(probing pocket depth, bleeding on probing, clinical attachment loss, plaque index), and 
radiographs but these conventional techniques are of limited usefulness because they are 
not sufficiently accurate to discern between previous periodontal disorders and present 
disease activity. For this reason, development of non-invasive diagnostic tools has presented 
a significant challenge to periodontology. Recently, gingival crevicular fluid (GCF) and 
saliva are in the middle of high-throughput techniques aimed to validate tests for the 
objective diagnosis of disease, monitoring, and prognostic indicators. Oral fluids contain 
locally and systemically derived mediators of periodontal disease, including pathogens, 
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host-response, and bone-specific markers (Kinney et al., 2007). Most biomarkers assessed in 
oral fluids are inflammatory cytokines, but some collagen degradation products and bone 
turnover-related molecules have emerged as possible markers of periodontal disease 
activity, too. Most biomarkers in GCF and saliva are indicators of soft-tissue inflammatory 
events (pathogens infection and host inflammatory response) that precede the destruction of 
the alveolar bone (Buduneli & Kinane, 2011).  
The detection of connective tissue-derived molecules may provide a more precise 
assessment of the breakdown of periodontal tissues, especially in light of the variability in 
the host response of different individuals (Giannobile et al. 2003).  
Among those which are the potential candidates for oral fluid-based diagnostics of 
periodontal disease are included: alkaline phosphatase, MMP-8, MMP-9, MMP-13, 
osteocalcin, osteonectin, osteopontin, and pyridinoline cross-linked carboxyterminal 
telopeptide of type I collagen (Arikan et al., 2008, 2011; Buduneli et al., 2008; Kinney et al., 
2007; Miller et al., 2006; Ozçaka et al., 2011) but the list is still open.  
Extracellular matrix molecules that are derived from the periodontium have been identified 
in GCF and saliva. Although growth factors function as molecular mediators of periodontal 
tissues repair their value as diagnostic biomarkers of periodontal tissue inflammation 
and/or destruction has yet elucidated.  
Research in this area has reported the assessment of GCF and salivary levels of several 
growth factors for their potential to diagnose periodontal disease, including EGF, TGF-ǃ, 
PDGF, HGF, and VEGF (Buduneli et al., 2001b; Chang et al., 1996; Gurkan et al., 2006; 
Hormia et al., 1993; Kamimoto et al., 2002; Sakallioglu et al., 2007; Wilczynska-Borawska et 
al., 2006).  
We were also interested to seek a relationship between salivary levels of growth factors and 
other molecules (MMPs, TIMPs, TNFǂ) related to host response and morphological and 
clinical changes observed in periodontitis. We compared the salivary concentration of TGF-
ǃ1 and CTGF in patients with periodontal disease and healthy control subjects. We didn’t 
obtain any significant difference for the salivary TGF-ǃ1 levels between healthy subjects and 
those with gingivitis. Only the values obtained for salivary TGF-ǃ1 in chronic periodontitis 
differ significantly from those found for control subjects but even in this case we observed a 
great difference between the smallest and the highest values (Pisoschi et al., 2010). This 
variation could be explained by the duration of the candidate risk factors on TGF-ǃ1 levels, 
being well known that periodontal disease is characterized by periods of active tissue 
destruction and quiescence. Our findings are in accordance with the results reported by 
other researchers for the variation of TGF-ǃ1 levels in patients with aggressive and chronic 
periodontitis (Gurkan et al., 2006). We also obtained a good correlation between salivary 
concentration and gingival expression of TGF-ǃ1. So far, we didn’t find any significant 
differences between salivary CTGF levels of patients with gingivitis, chronic periodontitis 
and controls (unpublished data). However, CTGF concentrations were higher in samples 
obtained from patients with type 2 diabetes associated gingival overgrowth (Pisoschi et al., 
2011). Regarding the level of circulating and oral fluids TGF-ǃ1 and CTGF, we agree with 
other researchers that variation in the analytical technique used in sample assessment might 
influence the values. 
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As we mentioned before, many reports sustained the importance of VEGF in the 
pathogenesis of periodontal disease. Therefore researchers attempted to find a correlation 
between GCF or salivary VEGF levels and its tissue expression in order to link this 
biomarker with the degree of periodontal damage. A recent study of Pradeep et al. (2011) 
that included patients with gingivitis and chronic periodontitis, reported an increase of 
VEGF concentration in GCF and a positive correlation between GCF and serum VEGF 
levels. Moreover a correlation between growth factor levels and clinical periodontal 
parameters before and after nonsurgical periodontal treatment was observed.  
Even the results of much research have confirmed the presence of several growth factors in 
GCF and saliva, for many of them the relation between their variation and the severity of the 
periodontal disease is still unclear. In the future, high-throughput proteomic and 
metabolomic technologies will be critical in establishing whether a biomarker could be 
accurate to diagnose and predict the severity of the periodontal disease.   
6. Growth factors as therapeutic tools in periodontal disease 
Therapeutic approaches for treatment of periodontitis are divided into two categories: i) 
anti-infective treatment, and ii) regenerative therapy. 
Several restoring techniques have been developed to regenerate periodontal tissues 
including guided tissue regeneration, bone grafting, and use of enamel matrix derivatives. 
Principles of guided tissue regeneration dictate that one of the goals of therapy is to 
modulate the repopulation of the wound with cells derived from the periodontal ligament 
rather than from the gingival tissues (Mumford et al., 2001). However, this technique is not 
associated with complete periodontal regeneration and a major complication and limiting 
factor in the achievement of periodontal regeneration is the presence of microbial 
periodontopathogens that contaminate wounds and reside on tooth surfaces as plaque-
associated biofilms.  
For more than a decade, periodontal researchers have been studying the potential of growth 
factors to achieve predictable periodontal regeneration. It is accepted that many growth 
factors are produced as inactive propeptides and stored in the cytoplasm (Anusaksathien & 
Giannobile, 2002). Cleavage of these propeptides and extracellular secretion of the mature 
forms provide the growth factors able to bind on their specific receptors. 
Growth factor therapies are directed to stimulate the specific progenitor cells which are 
responsible for the regeneration of mineralized and nonmineralized tissues in the 
periodontium but also to limit periodontal degradation. Therapeutic application of growth 
factors to restore damaged tissue aims the regeneration through biomimetic processes, or 
mimicking the processes that occur during embryonic and post-natal development 
(Schilephake, 2002). The complexity of these events suggests that creating an optimal 
regenerative environment requires the combination of different growth factors as found in 
natural processes. But also the use of a single recombinant growth factor may induce several 
molecular, biochemical and morphological cascades that will result in tissue regeneration. 
Almost all the growth factors are believed to be potential targets for the periodontal 
regenerative therapy but few strategies are subjected to various phases of clinical trials. 
Growth factors tested for their contribution to periodontal regeneration include PDGF,  
IGF-I, TGF-ǃ1, bFGF and some bone morphogenetic proteins (Giannobile et al., 1996, 2001; 
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Murakami et al., 1999; Taba et al., 2005). Results from the in vivo studies have shown that all 
of the above mentioned bioactive molecules, with the exception of TGF-ǃ1, exhibited ability 
to promote periodontal tissue regeneration and suggest that there may be cell-specific 
differences critical to periodontal wound healing that may be exploited in the development 
of new therapies.  
PDGF was the first growth factor to be evaluated in preclinical periodontal regenerative 
studies. In vitro studies had shown that exogenous application of PDGF at different 
concentrations (between 0,01 and 10 ng/ml) resulted in proliferation, migration and matrix 
synthesis in cultures of periodontal cells, including gingival and periodontal ligament 
fibroblasts, cementoblasts, preosteoblasts and osteoblasts in a time and dose dependence 
(Kaigler et al., 2006). From all its isoforms, PDGF-BB is the most effective on periodontal 
ligament cell mitogenesis and extracellular matrix macromolecules biosynthesis (Bartold, 
1993; Ojima et al., 2003). Even periodontal ligament fibroblasts and gingival fibroblasts have 
been shown to proliferate rapidly, gingival fibroblasts have been shown to fill a wound 
space significantly faster than periodontal ligament cells and this is an unwanted effect 
(Mumford et al., 2001). Studies on combination growth factor therapy involving PDGF and 
IGF-I have consistently promoted the periodontal regeneration (greater osseous and new 
attachment response) in animal models and lead to the first study in humans using growth 
factors for periodontal regeneration. In their human phase I/II clinical trial, PDGF/IGF-I 
were considered safe when applied topically to periodontal osseous lesions, resulting in a 
significant improvement in bone growth and fill of periodontal defects, compared with 
standard therapy (Howell et al., 1997, as cited by Kaigler et al., 2006). 
TGF-ǃ plays a significant role in periodontal regeneration. It is pleiotropic, and can 
stimulate or inhibit cell growth, an action that can interfere with its therapeutic use (Clokie 
& Bell, 2003). TGF-ǃ1 has been used for this application. The results of rhTGF-ǃ1 for 
periodontal regeneration have not been consistent preclinically as shown in dogs and sheeps 
investigations (Mohamed et al., 1998; Tatakis et al, 2000, as cited by Kraigler et al., 2006). 
These studies showed little advantages in new bone formation and no improvement in 
cementum regeneration when treated with rhTGF-ǃ1. Other research demonstrated that 
TGF-ǃ1 increased the amount of bone healing adjacent to dental implants in minipigs 
(Clokie & Bell, 2003). TGF-ǃ can also modulate other growth factors, such as PDGF, EGF, 
and FGF, by altering their cellular response or by inducing their expression.  Combined 
therapies, which involved PDGF and TGF-ǃ, have demonstrated synergistic effects and 
enhanced regeneration. Together, PDGF and TGF-ǃ have stimulated gingival fibroblasts and 
periodontal ligament cells. Some authors reported that TGF-ǃ, both alone and in 
combination with PDGF, led to a greater proliferation of periodontal ligament cells 
compared to the gingival fibroblasts. On the contrary, PDGF stimulated a significantly 
greater proliferation of gingival fibroblasts compared to periodontal ligament cells. Since 
periodontal proliferation at the diseased site is a desired feature in periodontal regeneration 
and because of the limited number of studies and inconsistent results, the use of TGF-ǃ will 
be further emphasized and thoroughly investigated. 
Several studies reported that FGFs can stimulate mitogenesis and chemotaxis in periodontal 
ligament cells (Takayama et al., 1997; Terranova et al., 1989). FGFs increased osteoblast 
proliferation, although they do not directly increase collagen production by differentiated 
osteoblasts. They have shown bFGF stimulates human endothelial and periodontal ligament 
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cell migration and proliferation on the dentin surfaces, and that the combination of bFGF with 
fibronectin can further enhanced periodontal ligament cell chemotaxis. Despite different 
concentrations of bFGF and different delivery systems used in the studies, all showed an 
improvement in the periodontal tissue regeneration. Studies that evaluated more than one 
concentration of bFGF suggested that its effects are dose dependent (Murakami et al., 2003).  
The results from preclinical and initial clinical studies using growth factors are encouraging; 
however, some limitations exist with respect to bone volume and predictability. Trials 
utilizing topical growth factors have revealed difficulties in maintaining therapeutic levels 
of proteins and to obtain optimal outcomes in vivo; of great importance is to enhance the 
half-life of growth factors and their biological stability (Yun et al., 2010). Based on the results 
of studies that support in vitro biological functions of FGFs for tissue regeneration, the 
largest in vivo study in the field of periodontal regenerative therapy was initiated by 
Kitamura’s team. This was a human clinical trial projected to determine the safety and 
efficiency of FGF-2 for clinical application. Their results support that topical application of 
three doses of FGF-2 during periodontal surgery could be efficient for the regeneration of 
periodontal tissue (Kitamura et al., 2008).  
Future clinical application of growth factors in the regeneration of periodontal tissues will 
be achieved when their biological functions are maximized by the appropriate use of 
biomaterials and stem cells.  
7. Conclusions  
The biology of periodontal connective tissues is important to be understood in terms of 
development, pathology, regeneration and interrelationship between periodontitis 
interactions and various systemic diseases. Although growth factors function as molecular 
mediators of periodontal tissues, their value as diagnostic biomarkers for periodontal tissue 
inflammation and/or fibrosis is yet to be elucidated. High-throughput technologies applied 
for assessment of gingival crevicular fluid and saliva will give new promises for the use of 
growth factors as objective biomarkers in periodontal disease.  
In earlier studies, the application of growth factors provided different degrees of success in 
stimulating wound healing in the periodontal areas. There is an imperious need to further 
evaluate the biologic mechanisms that may be responsible for the promotion of tissue 
regeneration by growth factors. Finally, studies on growth factors delivery and improved 
stability seek evidence to conclusively support the addition of growth factors strategy to the 
therapeutic protocol for regeneration of periodontal tissues.  
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